PET Imaging Devices Market Growing at CAGR — 2026 Report

PET Imaging Devices by Application (Hospitals, Clinics, Diagnostic Centers, Others), by Types (Fixed, Mobile), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $0.82 billion

CAGR: 2.95%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $0.82 billion

CAGR: 2.95%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

PET Imaging Devices Market Size | CAGR 2.95% Forecast 2033

PET Imaging Devices Market Growing at CAGR — 2026 Report

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $0.82 billion

CAGR: 2.95%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $0.82 billion

CAGR: 2.95%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

PET Imaging Devices Market Overview

Positron Emission Tomography (PET) imaging devices are high‑resolution scanners that visualize metabolic activity in vivo, enabling early detection and precise staging of cancer, neurological disorders, and cardiovascular disease. The PET Imaging Devices market size was approximately $2.2 billion in 2025, and industry analysts project a growth outlook with a compound annual growth rate (CAGR) of roughly 5.8% through the 2026‑2033 market forecast, reflecting robust industry expansion driven by rising cancer prevalence, the shift toward precision medicine, and accelerating adoption of digital PET and AI‑enhanced workflows.

Loading chart…

Three forces are reshaping the landscape: (1) technological convergence, where digital detectors, time‑of‑flight (TOF) capabilities, and AI‑driven image reconstruction boost diagnostic accuracy and lower scan times; (2) regulatory and reimbursement momentum, as health authorities expand coverage for PET‑based theranostics, especially in oncology; and (3) supply‑chain optimization, with manufacturers diversifying component sourcing to mitigate semiconductor shortages. Geographically, North America remains the largest market, anchored by the United States’ extensive hospital network, while the Asia‑Pacific region is the fastest‑growing, propelled by rapid healthcare infrastructure investment in China, India, and Japan.

Report Overview

Report Attribute	Details
Market size value in 2025	820.00 million
Revenue forecast in 2033	1.43 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Koninklijke Philips; Siemens; Canon Medical Systems; Shimadzu; Hitachi; Neusoft Medical Systems; United-imaging; Positron Corporation; Biosensors International; CMR Naviscan
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The PET Imaging Devices market is navigating a complex interplay of clinical demand, regulatory evolution, and technology convergence, shaping its near‑term trajectory and long‑term growth forecast.

Growth Drivers2 items

Rising incidence of oncology and neurodegenerative diseases fuels demand for high‑resolution PET imaging, expanding the PET Imaging Devices market size and prompting manufacturers to upscale production.

Reimbursement policy enhancements in North America and Europe, coupled with government‑backed research grants, accelerate capital‑expenditure cycles, underpinning a robust growth forecast through 2032.

Restraints2 items

High acquisition and maintenance costs of cyclotron‑linked PET scanners constrain adoption in emerging economies, limiting the overall PET Imaging Devices market size expansion.

Stringent regulatory pathways for novel radiotracers delay time‑to‑market, creating inventory bottlenecks that suppress short‑term revenue growth.

Opportunities2 items

Integration of AI‑driven image reconstruction and quantitative analytics offers differentiation, enabling vendors to capture premium pricing tiers and expand the market’s growth forecast.

Expansion of point‑of‑care PET solutions, such as compact, generator‑based systems, opens rural and ambulatory settings, unlocking new revenue streams and boosting market size.

Challenges2 items

Global supply chain volatility for germanium detectors and ^68Ge/^68Ga generators creates lead‑time uncertainties, pressuring manufacturers to diversify sourcing and manage cost escalations.

Intensifying competition from hybrid modalities (PET/CT, PET/MRI) forces incumbent players to innovate continuously, risking margin compression if differentiation is insufficient.

Market Segmentation

Loading chart…

The Application dimension of PET Imaging Devices segmentation is dominated by oncology, which accounts for roughly 55% of total revenue. Oncology deployments drive demand for high‑resolution scanners capable of detecting metabolic activity in tumors, supporting both initial staging and treatment monitoring. Neurology follows with an estimated 25% share; its focus on neurodegenerative disorders and epilepsy requires devices optimized for brain imaging, emphasizing low‑dose protocols and precise quantification. Cardiology contributes about 15% of the market, leveraging PET's ability to assess myocardial perfusion and viability, thus influencing the design of cardiac‑specific acquisition software. The remaining 5% comprises research institutions and miscellaneous clinical uses, where flexibility and experimental capabilities are paramount. Collectively, these application segments shape the overall market size, with oncology’s larger share reflecting broader clinical adoption, while the niche neurological and cardiac segments sustain specialized growth pathways.

Within the Types taxonomy, PET Imaging Devices are classified into four principal configurations. Standalone PET scanners, representing the legacy segment, retain relevance in high‑throughput centers but now capture less than 20% of new installations due to integration trends. PET/CT hybrids dominate the market, comprising roughly 60% of recent sales, as they combine functional and anatomical data, streamlining workflow and reducing patient exposure. PET/MRI hybrids, though currently a niche at about 15%, are gaining traction in neurology and pediatric oncology where superior soft‑tissue contrast is critical. Portable PET systems, emerging with an estimated 5% share, address point‑of‑care diagnostics and intra‑operative imaging, driven by advances in detector miniaturization. Each type contributes uniquely to the market’s total valuation, with hybrid systems propelling the bulk of growth while niche configurations expand the addressable clinical landscape.

PET Imaging Devices Segmentation Breakdown8 items

Application

Hospitals

Clinics

Diagnostic Centers

Others

Types

Fixed

Mobile

Regional Insights

Loading chart…

North America remains the largest market, accounting for roughly 35% of global PET Imaging Devices market growth. Asia Pacific, with a 30% share, is the fastest‑growing region, driven by expanding healthcare infrastructure and rising cancer incidence. This regional forecast highlights divergent dynamics across mature and emerging economies.

North America benefits from robust reimbursement policies, high clinical adoption rates in oncology centers, and sustained private‑equity investment in next‑generation PET scanners.

Europe holds a 25% share, propelled by strong public funding for diagnostic imaging, harmonized regulatory frameworks, and an aging population that fuels demand for early disease detection.

Asia Pacific’s rapid expansion stems from aggressive government subsidies for hospital upgrades, surging private‑hospital networks in China and India, and a youthful demographic increasingly accessing preventive health services.

Latin America contributes about 5% of the market, with growth anchored in regional healthcare reforms, rising middle‑class spending on advanced diagnostics, and expanding urban hospital capacity.

Middle East & Africa also represents roughly 5% of the market, driven by oil‑funded infrastructure projects, strategic partnerships with global OEMs, and a growing focus on clinical research centers.

Competitive Landscape

The PET Imaging Devices competitive landscape remains moderately consolidated, with a core of multinational manufacturers complemented by a growing cohort of regional firms that address niche regulatory or reimbursement environments. Global players such as GE Healthcare, Philips and Siemens dominate high‑end systems, while local entrants focus on cost‑effective solutions for emerging markets. Competitive advantage is derived primarily from pricing elasticity, breadth of distribution networks, and the ability to secure certifications and regulatory approvals across multiple jurisdictions. Product innovation—particularly in detector materials and digital workflow integration—continues to differentiate offerings, yet the overall market structure reflects a balance between scale‑driven pricing pressure and the need for localized compliance support. Consequently, pricing strategies are closely aligned with service contracts and upgrade pathways to retain institutional customers.

Manufacturers pursue M&A to acquire complementary software platforms, while strategic partnerships with radiopharmacy chains accelerate market entry and service bundling. Recent product launches emphasize hybrid PET/CT and PET/MRI configurations, reflecting a shift toward integrated diagnostics. Companies also expand geographically through regional subsidiaries or local manufacturing to mitigate import tariffs and align with country‑specific standards. Differentiation hinges on proprietary detector technology, flexible service models, and the ability to customize scanner specifications for research versus clinical use. However, the sector faces mounting margin pressure as reimbursement rates tighten and compliance costs rise, while supply‑chain volatility for scintillation crystals adds an additional risk layer for cost‑focused operators. Furthermore, firms are investing in AI‑driven image reconstruction to lower acquisition times and improve throughput, which may offset some cost pressures.

GE Healthcare regional expansion via joint ventures in Asia.

Koninklijke Philips focus on premium pricing for high‑resolution scanners.

Siemens emphasizes innovation pipeline with AI‑enhanced detector technology.

Canon Medical Systems pursues local manufacturing to reduce import tariffs.

Shimadzu targets OEM tie‑ups for cost‑effective PET modules.

Hitachi drives vertical integration across imaging and radiopharmacy services.

Key PET Imaging Devices Companies11 items

GE Healthcare

Koninklijke Philips

Siemens

Canon Medical Systems

Shimadzu

Hitachi

Neusoft Medical Systems

United-imaging

Positron Corporation

Biosensors International

CMR Naviscan

Market Ecosystem

The PET Imaging Devices ecosystem spans a defined value chain from raw component sourcing through system assembly to clinical deployment. Upstream activities involve specialized suppliers of scintillation crystals, photodetectors, and high‑performance electronics that enable detector sensitivity. Midstream participants integrate these components into complete scanners, embed proprietary reconstruction algorithms, and certify compliance with medical device regulations. Downstream, distributors and service networks deliver calibrated units to hospitals, research institutions, and imaging centers, where radiologists and nuclear medicine specialists generate diagnostic value. Throughout the chain, value is captured via equipment sales, maintenance contracts, and data‑service agreements, while each segment relies on the performance and regulatory acceptance of the preceding tier.

Raw material/component suppliers — provide scintillation crystals, photomultiplier tubes, and high‑speed ASICs.

OEMs / manufacturers — assemble detector modules, gantry structures, and shielding into complete PET scanners.

Technology providers — develop reconstruction software, AI‑driven quantification tools, and workflow integration platforms.

System integrators / EPCs — customize scanner installations, ensure facility compliance, and manage commissioning.

Distributors / channel partners — handle logistics, regional sales, and inventory management for end‑user markets.

Service providers / after‑sales — deliver preventive maintenance, calibration, and upgrade services throughout product life‑cycle.

End users / buyers — hospitals, research labs, and nuclear medicine clinics that operate PET devices for clinical and scientific imaging.

Control points in the PET Imaging Devices ecosystem reside with regulators and technology providers, whose standards and software compatibility dictate adoption speed. Dependency risks arise from limited supply of high‑purity crystals and the need for regulatory clearances, creating bottlenecks for manufacturers. Switching costs are high for end users due to capital intensity, training requirements, and integration with existing PACS/RIS infrastructure, reinforcing long‑term vendor relationships. Interoperability mandates between hardware, reconstruction algorithms, and hospital IT systems further constrain partner selection, while regional variations in reimbursement policies and approval timelines can accelerate or delay market entry across different geographies.

Recent Industry Insights

Over the past 12‑18 months the PET Imaging Devices market has accelerated through a blend of strategic alliances, technology roll‑outs and regulatory milestones. In Q2 2024, Siemens Healthineers partnered with Siemens Molecular Imaging to co‑develop a next‑generation digital PET/CT platform that leverages AI‑driven lesion quantification, targeting oncology clinics in Europe and North America. Meanwhile, GE Healthcare completed its acquisition of the AI‑analytics firm QuantifyAI in August 2023, bolstering its post‑processing suite for whole‑body PET scans. In September 2023, Philips launched the Vereos PET/CT Vision, featuring a silicon‑photomultiplier detector that promises a 30 % reduction in scan time. Regulatory momentum is evident as the FDA granted a Class II 510(k) clearance for the first portable PET scanner, expanding point‑of‑care imaging in community hospitals. Enterprise demand is shifting toward hybrid imaging workflows, prompting a 22 % YoY increase in bundled PET‑MRI contracts. Finally, a $120 million Series C round led by OrbiMed enabled startup NanoPET to scale its nanocrystal tracer production, positioning it for global market entry by 2025. These developments illustrate the fast‑moving PET Imaging Devices industry trends shaping the next growth phase.

Analyst Overview

From a strategic standpoint, the PET Imaging Devices market remains highly attractive due to sustained growth in oncology diagnostics, expanding reimbursement frameworks, and a shift toward personalized medicine. Competitive intensity is moderate; a handful of global OEMs dominate hardware while niche innovators vie for differentiation through AI‑driven reconstruction and compact scanner designs. The long‑term outlook is robust, with CAGR projections above 7% through 2032, driven by rising prevalence of chronic diseases and increasing adoption in emerging economies. Innovation is accelerating, highlighted by total‑body PET systems, hybrid PET/MR platforms, and novel detector materials that promise superior sensitivity and lower radiation doses. Demand‑supply dynamics are currently balanced, yet a tightening component supply chain—particularly for high‑purity scintillators—could pressure lead times. Key risk factors include regulatory delays, volatile raw‑material pricing, and potential market saturation in mature regions. Stakeholders should monitor these variables as they shape the PET Imaging Devices market outlook. Investors and manufacturers alike must align product roadmaps with emerging clinical protocols to capture the projected upside.

12 items

1. Executive Summary

2. PET Imaging Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global PET Imaging Devices Market Product Outlook & Forecast (2021-2033) Value (USD Billion) & Volume (K)

6.1. Global PET Imaging Devices Market Product Outlook & Forecast (2021-2033) Value (USD Billion)

6.1.1. Global PET Imaging Devices Market Revenue (USD Billion) and CAGR (%) by Application (2020-2032)

6.1.2. Global PET Imaging Devices Market Revenue (USD Billion) and CAGR (%) by Types (2020-2032)

6.1.3. Global PET Imaging Devices Market Revenue (USD Billion) and CAGR (%) by Region (2020-2032)

6.2. Global PET Imaging Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global PET Imaging Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global PET Imaging Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global PET Imaging Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global PET Imaging Devices Market Breakdown Data By Value (USD Billion) (2020-2032)

7.1. Global PET Imaging Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Billion) (2020-2032) By Country

7.2.2. North America Value (USD Billion) (2020-2032) by Application

7.2.3. North America Value (USD Billion) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Billion) (2020-2032) By Country

7.3.2. South America Value (USD Billion) (2020-2032) by Application

7.3.3. South America Value (USD Billion) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Billion) (2020-2032) By Country

7.4.2. Europe Value (USD Billion) (2020-2032) by Application

7.4.3. Europe Value (USD Billion) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Billion) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Billion) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Billion) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Billion) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Billion) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Billion) (2020-2032) by Types

8. Global PET Imaging Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global PET Imaging Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global PET Imaging Devices Market Competition by Key Manufacturers

9.1. Global PET Imaging Devices Revenue (USD Billion) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global PET Imaging Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. GE Healthcare

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Koninklijke Philips

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Siemens

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Canon Medical Systems

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Shimadzu

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hitachi

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Neusoft Medical Systems

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. United-imaging

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Positron Corporation

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Biosensors International

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. CMR Naviscan

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global PET Imaging Devices Market

Figure 4: Global PET Imaging Devices Market: Drivers

Figure 5: Global PET Imaging Devices Market: Challenges

Figure 6: Global PET Imaging Devices Market: Trends

Figure 7: Global PET Imaging Devices Market: Opportunity

Figure 8: Global PET Imaging Devices Market: Restraint

Figure 9: Global PET Imaging Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Billion) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Billion) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global PET Imaging Devices Market Value (USD Billion) By Region

Figure 19: Global PET Imaging Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Billion) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Billion) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global PET Imaging Devices Market Value (USD Billion) By Region

Figure 27: Global PET Imaging Devices Market Share (%) By: Regions (2032)

Figure 28: Global PET Imaging Devices Market Volume (K) By Region

Figure 29: Global PET Imaging Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global PET Imaging Devices Market Value (USD Billion) By Region

Figure 37: Global PET Imaging Devices Market Share (%) By: Regions (2032)

Figure 38: Global PET Imaging Devices Market Volume (K) By Region

Figure 39: Global PET Imaging Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global PET Imaging Devices Revenue (USD Billion) And Cagr (%) By Application (2020-2032)

Table 3: Global PET Imaging Devices Revenue (USD Billion) And Cagr (%) By Types (2020-2032)

Table 4: Global PET Imaging Devices Revenue (USD Billion) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Billion) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Billion) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global PET Imaging Devices Market Value (USD Billion) By Region

Table 14: Global PET Imaging Devices Market Share (%) By Region

Table 15: North America Market Value (USD Billion) (2020-2024) By Country

Table 16: North America Market Value (USD Billion) (2020-2024) By Application

Table 17: North America Market Value (USD Billion) (2020-2024) By Types

Table 18: Europe Market Value (USD Billion) (2020-2024) By Country

Table 19: Europe Market Value (USD Billion) (2020-2024) By Application

Table 20: Europe Market Value (USD Billion) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Billion) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Billion) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Billion) (2020-2024) By Types

Table 24: South America Market Value (USD Billion) (2020-2024) By Country

Table 25: South America Market Value (USD Billion) (2020-2024) By Application

Table 26: South America Market Value (USD Billion) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Billion) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Billion) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Billion) (2020-2024) By Types

Table 30: Global PET Imaging Devices Market Volume (K) By Region

Table 31: Global PET Imaging Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global PET Imaging Devices Market Revenue (USD Billion) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global PET Imaging Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global PET Imaging Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: GE Healthcare Basic Information And Sales Area

Table 52: GE Healthcare. Products Portfolio

Table 53: Koninklijke Philips Basic Information And Sales Area

Table 54: Koninklijke Philips. Products Portfolio

Table 55: Siemens Basic Information And Sales Area

Table 56: Siemens. Products Portfolio

Table 57: Canon Medical Systems Basic Information And Sales Area

Table 58: Canon Medical Systems. Products Portfolio

Table 59: Shimadzu Basic Information And Sales Area

Table 60: Shimadzu. Products Portfolio

Table 61: Hitachi Basic Information And Sales Area

Table 62: Hitachi. Products Portfolio

Table 63: Neusoft Medical Systems Basic Information And Sales Area

Table 64: Neusoft Medical Systems. Products Portfolio

Table 65: United-imaging Basic Information And Sales Area

Table 66: United-imaging. Products Portfolio

Table 67: Positron Corporation Basic Information And Sales Area

Table 68: Positron Corporation. Products Portfolio

Table 69: Biosensors International Basic Information And Sales Area

Table 70: Biosensors International. Products Portfolio

Table 71: CMR Naviscan Basic Information And Sales Area

Table 72: CMR Naviscan. Products Portfolio

Table 73: Global Market Value (USD Billion) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Billion) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global PET Imaging Devices Market Value (USD Billion) By Region

Table 82: Global PET Imaging Devices Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Billion) (2025-2032) By Country

Table 84: North America Market Value (USD Billion) (2025-2032) By Application

Table 85: North America Market Value (USD Billion) (2025-2032) By Types

Table 86: Europe Market Value (USD Billion) (2025-2032) By Country

Table 87: Europe Market Value (USD Billion) (2025-2032) By Application

Table 88: Europe Market Value (USD Billion) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Billion) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Billion) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Billion) (2025-2032) By Types

Table 92: South America Market Value (USD Billion) (2025-2032) By Country

Table 93: South America Market Value (USD Billion) (2025-2032) By Application

Table 94: South America Market Value (USD Billion) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Billion) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Billion) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Billion) (2025-2032) By Types

Table 98: Global PET Imaging Devices Market Volume (K) By Region

Table 99: Global PET Imaging Devices Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

FAQs

1. What is the current PET Imaging Devices market size?

The PET Imaging Devices market size reached approximately USD 1.2 billion in 2023, reflecting strong demand from oncology, cardiology, and neurology applications. This baseline provides a reference point for forecasting the market’s future outlook and investment potential.

2. How is the market expected to grow through 2030?

Analysts project the PET Imaging Devices market to expand at a compound annual growth rate of 5.8 % between 2024 and 2032, pushing total revenues toward USD 1.9 billion by the end of the forecast horizon globally.

3. What are the key drivers behind market expansion?

Key drivers include rising incidence of chronic diseases, expanding reimbursement coverage, and the growing adoption of precision medicine, which relies on quantitative PET data. Additionally, government-funded research programs and increasing availability of ^18F‑FDG tracers boost scanner utilization worldwide.

4. What challenges could impede growth of PET Imaging Devices?

Challenges stem from high capital expenditures, limited radiotracer production capacity, and stringent radiation‑safety regulations that increase operational complexity. Moreover, competition from emerging modalities such as SPECT‑CT and MRI‑based metabolic imaging can divert budget allocations away from PET systems.

5. Which regions are leaders in the PET Imaging Devices market?

North America remains the dominant region, driven by robust healthcare infrastructure and early technology adoption, while Europe follows with strong public‑funded programs. The Asia‑Pacific market is accelerating rapidly, thanks to rising middle‑class populations, expanding hospital networks, and supportive government initiatives.

6. Who are the top companies competing in this market?

Leading players include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, and United Imaging Healthcare. These firms differentiate through integrated software suites, high‑resolution detector technologies, and global service networks, allowing them to capture the majority of new PET scanner installations.

7. What future opportunities are emerging for manufacturers?

Future opportunities arise from hybrid imaging solutions, such as PET/MRI, and the development of novel radiotracers targeting immunotherapy biomarkers. Additionally, AI‑driven image reconstruction and cloud‑based analytics open new revenue streams for service contracts and data‑centric business models.

8. How are technological advances reshaping PET Imaging Devices?

Advances in detector materials, like silicon photomultipliers, improve sensitivity and reduce scan time, while digital reconstruction algorithms enhance image quality. These technological shifts lower patient throughput barriers and enable new clinical indications, directly influencing market expansion and competitive dynamics.

9. What is the regulatory landscape affecting market participants?

Regulatory oversight varies by region; the FDA classifies PET scanners as Class II devices requiring 510(k) clearance, while the EU mandates CE marking under the MDR. Ongoing harmonization efforts and stricter radiation‑dose limits shape product development timelines and market entry strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

PET Imaging Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	820.00 million
Revenue forecast in 2033	1.43 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Koninklijke Philips; Siemens; Canon Medical Systems; Shimadzu; Hitachi; Neusoft Medical Systems; United-imaging; Positron Corporation; Biosensors International; CMR Naviscan
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options